The cost of waiting is not evenly distributed. Rural and critical access hospitals report under 50 percent adoption of even basic predictive tools, compared with 86 percent among top-tier system-affiliated hospitals. Every year without a bridge widens that gap, and it widens it fastest for the hospitals with the least room to absorb it. The post A Market, Not a Mandate, Is the Fastest Way to Bring AI Into Hospitals appeared first on MedCity News.

Women’s health experts had mixed reactions to the Trump administration’s executive order on women’s health. The post How Experts Are Reacting to Trump’s Women’s Health Executive Order appeared first on MedCity News.

Corxel Pharmaceuticals is catching up to others with oral GLP-1 obesity drugs, but the biotech claims its small molecule could offer better tolerability compared to the rest of its class. The SPAC merger taking Corxel public is expected to close in the first half of 2027, which is when the biotech plans to start a Phase 3 trial. The post Obesity Biotech Corxel Is Going Public in a Merger as Oral GLP-1 Heads to Phase 3 appeared first on MedCity News.

Sutter Health, a nonprofit healthcare system based in Sacramento, California, is expanding its digital chronic disease management program, Sutter Sync, to include patients with heart failure. The expansion adds a remote monitoring technology from San Francisco-based medical tech company Bodyport. The program expansion comes as health systems look for ways to identify deterioration in a low acuity environment before patients reach the point of needing emergency hospitalization. The post Sutter Health Expands Remote Monitoring Program to Patients with Heart Failure appeared first on MedCity News.

CMS has introduced uncertainty about whether Medicare will participate in that modernization or preserve the old system under a different name. The consequences extend far beyond billing The post In a Maternity Care Crisis, CMS Undermines Efforts To Modernize Care appeared first on MedCity News.

[Sponsored] For US biotech companies developing rare disease therapies, decisions about clinical evidence, patient populations and regulatory advice can have consequences in Europe long before a marketing application is submitted. The post FDA Alignment Is a Starting Point, Not a Rare Disease Strategy for the European Market appeared first on MedCity News.

CareValidate expanded its HRT offering for telehealth companies, combining hormone therapy with provider access, pharmacy services and AI-powered care coordination. The post CareValidate Launches Expanded HRT Offering appeared first on MedCity News.

Lycia Therapeutics’ protein-degrading drugs are based on the research of Carolyn Bertozzi, a Stanford chemistry professor and Nobel laureate. Lycia’s lead drug candidate is in development for food allergy, where it could compete against the blockbuster Roche drug Xolair. The post Lycia Lands a $317M IPO for Inflammation Drugs Based on Nobel Prize-Winning Science appeared first on MedCity News.

The MATCH IT Act aims to reduce patient matching errors. But a model used by vital records systems could provide a better solution. The post Congress’s Patient Matching Fix Won’t Work — Here’s What Would appeared first on MedCity News.

In most organizations the default access model was built for patient care, not for protecting colleagues. A nurse on another unit, a resident who rotated with them, a department administrator: any of them may technically be able to open the record, even when policy says they should not. The post Physician Mental Health and Health System Privacy: Why Doctors Avoid Their Own EHR appeared first on MedCity News.

Fractyl Health reported positive six-month trial results from an investigation of its Revita procedure last week, but shares of Fractyl stock dropped steeply on October 16 immediately following the announcement. Despite the positive findings, the stock’s sharp decline highlighted a contrast between the clinical findings and the market’s response. The post Fractyl’s Weight Maintenance Device Meets Clinical Goal, but Shares Nosedive, Layoffs Follow appeared first on MedCity News.

MedTech Conference panelists cited inflammation research, listening to women, clinical trial representation and investment as priorities for women’s cardiovascular health. The post Where Are the Biggest Opportunities in Women’s Cardiovascular Health? appeared first on MedCity News.

Gilead Sciences is getting global rights to an experimental PepStar Therapeutics oral peptide designed to inhibit the IL-23 receptor to treat inflammatory bowel disease. It could compete against Johnson & Johnson’s Icotyde, an oral peptide that blocks the same target and is also in development for IBD. The post Gilead to Pay $1.3B for Oral Peptide That Could Rival J&J’s New Immunology Pill appeared first on MedCity News.

Ultimately, while clinical training teaches nurses how to care for patients within a system, business education empowers them to design, protect, and scale the system. The post Why an Independent NP Practice Requires an Undergraduate Business Foundation appeared first on MedCity News.

Amazon, Axon Enterprise, Google, Meta and Oracle backed expanding electronic prior authorization to self-funded employer health plans. The post Amazon, Google and Other Major Employers Back CMS Prior Auth Effort appeared first on MedCity News.